The Danish Medicines Agency said it would ask European authorities to review two new studies that point to a link between Novo Nordisk A/S’s blockbuster shot Ozempic and a rare form of vision loss.

The Danish Medicines Agency said it would ask European authorities to review two new studies that point to a link between Novo Nordisk A/S’s blockbuster shot Ozempic and a rare form of vision loss.

Danish studies have found a potential link between the diabetes drug Ozempic and a rare eye condition called non-arteritic anterior ischemic optic neuropathy (NAION). The Danish Medicines Agency has requested the European Pharmacovigilance Risk Assessment Committee to evaluate these findings,

Danish health authorities said on Monday they would ask the European Union's drug regulator to review the findings of two Danish studies linking Novo Nordisk's popular diabetes drug Ozempic to a rare sight-threatening eye condition.